BacterOMIC takes antibiotic susceptibility testing (AST) to the next level by offering quantitative evaluation of all clinically relevant antibiotics in a single test. BacterOMIC offers also synergy panels that identify synergistic pairs of antibiotics. BacterOMIC uses the most trusted microdilution AST, combined with cutting-edge microfluidics to provide unprecedented information density on a single disposable panel. Our technology will deliver the first fully comprehensive tests – a single panel contains up to 60 clinically relevant antibiotics, or up to 20 checkerboard combinations of antibiotics.  For each antibiotic BacterOMIC provides a true MIC value – the lowest concentration of an antimicrobial that will inhibit the growth of bacteria. While analysis requires 6-18 hours, it delivers complete information, eliminating multiple days of delays associated with additional testing, all to direct targeted antibiotic treatment already after the first test. BacterOMIC is the only system in the world that will provide full information about all clinically relevant antibiotics, and allows for automatic testing of combinations of antibiotics, which gives it a clear technological advantage over the competition, improves the outcomes, reduces the risk of complications in antibiotic treatment and reduces cost of hospitalization and treatment.